0001209191-15-005233.txt : 20150120 0001209191-15-005233.hdr.sgml : 20150119 20150120172803 ACCESSION NUMBER: 0001209191-15-005233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150120 FILED AS OF DATE: 20150120 DATE AS OF CHANGE: 20150120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SWAIN PAULA J CENTRAL INDEX KEY: 0001236934 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 15536880 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION STREET 2: 3160 PORTER DRIVE CITY: PALO LATO STATE: CA ZIP: 94304 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-01-20 0 0000879169 INCYTE CORP INCY 0001236934 SWAIN PAULA J 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP, Human Resources Common Stock 2015-01-20 4 M 0 17500 3.11 A 38583 D Common Stock 2015-01-20 4 S 0 17500 74.17 D 21083 D Non-Qualified Stock Option (right to buy) 3.11 2015-01-20 4 M 0 17500 0.00 D 2016-01-26 Common Stock 17500 51469 D Represents weighted average sale price. Actual sale prices ranged from $73.19 - $74.81. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Beginning January 27, 2009, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ Paula Swain 2015-01-20